Point72 Asset Management, L.P. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$8,566,353
+6683.7%
335,278
+7514.8%
0.02%
Q2 2023$126,278
-93.4%
4,403
-94.5%
0.00%
-100.0%
Q1 2023$1,926,900
+76.1%
80,388
+24.6%
0.01%
+50.0%
Q4 2022$1,093,920
-88.0%
64,500
-89.5%
0.00%
-89.2%
Q3 2022$9,146,000
-36.4%
617,124
-32.4%
0.04%
-39.3%
Q2 2022$14,376,000
+25.4%
913,323
+114.8%
0.06%
+32.6%
Q1 2022$11,463,000
+10.0%
425,200
+90.7%
0.05%
-32.4%
Q2 2020$10,424,000223,0130.07%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders